The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)-6-methyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine ID: ALA4756013
PubChem CID: 58290846
Max Phase: Preclinical
Molecular Formula: C32H42N6O3S
Molecular Weight: 590.79
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2c(Nc3ccccc3S(=O)(=O)C(C)C)nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC(C)C)nc2[nH]1
Standard InChI: InChI=1S/C32H42N6O3S/c1-19(2)41-28-18-24(23-12-14-38(7)15-13-23)21(5)16-27(28)35-32-36-30-25(17-22(6)33-30)31(37-32)34-26-10-8-9-11-29(26)42(39,40)20(3)4/h8-11,16-20,23H,12-15H2,1-7H3,(H3,33,34,35,36,37)
Standard InChI Key: FAPJXRFDCACRNM-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
11.8963 -4.2252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4839 -4.8127 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.6990 -4.0101 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1991 -5.2252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1980 -6.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9128 -6.4655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6293 -6.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6265 -5.2216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9111 -4.8124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9086 -3.9874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6218 -3.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3354 -3.9855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0482 -3.5716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0462 -2.7456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7637 -3.9823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7658 -4.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0512 -5.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0530 -6.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7691 -6.4519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4849 -6.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4796 -5.2102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7734 -7.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0586 -7.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0598 -8.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7741 -8.9246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4888 -8.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4893 -7.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1908 -4.7920 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9086 -5.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6198 -4.7806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9153 -6.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3393 -6.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7701 -5.2255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0555 -4.8132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7703 -6.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0041 -2.2006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6156 -2.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3288 -2.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1552 -1.5336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3354 -1.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7741 -9.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9204 -0.7379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 2 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 38 1 0
37 11 1 0
13 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
19 22 1 0
21 28 1 0
28 29 1 0
29 30 1 0
29 31 1 0
18 32 1 0
2 33 1 0
33 34 1 0
33 35 1 0
37 38 2 0
36 37 1 0
38 39 1 0
39 40 1 0
40 36 2 0
25 41 1 0
40 42 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 590.79Molecular Weight (Monoisotopic): 590.3039AlogP: 6.84#Rotatable Bonds: 9Polar Surface Area: 112.24Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.77CX Basic pKa: 8.96CX LogP: 6.40CX LogD: 4.83Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.19Np Likeness Score: -1.19
References 1. Michellys PY,Chen B,Jiang T,Jin Y,Lu W,Marsilje TH,Pei W,Uno T,Zhu X,Wu B,Nguyen TN,Bursulaya B,Lee C,Li N,Kim S,Tuntland T,Liu B,Sun F,Steffy A,Hood T. (2016) Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors., 26 (3.0): [PMID:26750252 ] [10.1016/j.bmcl.2015.11.049 ]